A team at Brigham and Women's Hospital discovered a microRNA in the microbiome that increases when multiple sclerosis peaks. When they gave a synthetic version of the microRNA to mice as an oral treatment, it suppressed symptoms of the disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,